Purpose: A case of heparin-induced thrombocytopenia (HIT) complicated by warfarin-induced skin necrosis (WISN) is reported. Summary: A patient with a history of hypertension, heart failure, and ... What is warfarin-induced skin necrosis?
Warfarin is an anticoagulant medicine (blood thinner). Warfarin-induced skin necrosis refers to a rare condition in which there is paradoxical blood clotting. Blood clots block the blood vessels and cause necrosis, where an area of skin is destroyed. The blood clots interrupt the blood supply to the skin, causing necrosis.
warfarin skin necrosis, Protein C is an innate anticoagulant, and as warfarin further decreases protein C levels, it can lead to massive thrombosis with necrosis and gangrene of limbs. Prescribers of warfarin should be aware of induction of skin necrosis as a rare, but known, adverse effect of the medication. Adequate bridge therapy may decrease the likelihood of the development of this life-threatening condition. Herein, we review the clinical and histologic features helpful for differentiating warfarin-induced skin necrosis and report a case illustrative of the diagnostic difficulty that may at times be encountered in clinical practice. Warfarin-induced skin necrosis is a rare condition thought to be due to microvascular thrombosis and ischemia and is commonly related to protein C deficiency.
warfarin skin necrosis, Recognition of WISN is critical to reduce morbidity and mortality. Warfarin-induced skin necrosis (WISN) is a rare but serious adverse effect of warfarin that typically occurs during the initial days of therapy. However, late-onset WISN, occurring months or years after stable anticoagulation, is an unusual and poorly understood phenomenon. Warfarin-induced skin necrosis (WSN) is a rare but potentially life-threatening complication of anticoagulation therapy, typically emerging within the first few days of warfarin initiation. This lesson presents the case of a patient with extensive skin necrosis after inappropriately prolonged warfarinisation and delayed recognition. The condition is briefly reviewed to highlight key features and risk factors.
Introduction Coumadin-induced skin necrosis (CISN) is a rare, unusual, and unpredictable integumentary complication of anticoagulant therapy. Also known as warfarin-induced skin necrosis (WISN), the dermatologic complication occurs in 0.01 to 0.1 percent of warfarin-treated patients.
